ALNOV:EPA
Novacyt SA
0,44 €
0,00%
(0,00) 1D
19. stu, 17:35:19 GMT+1 · EUR
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za ALNOV...
Otvori
0,44 €
Najviša
0,45 €
Najniža
0,44 €
Trž. kap.
31,86 mil.
Prosj. kol.
136,90 tis.
Količina
0,00
52-tjed. najviša
1,04 €
52-tjed. najniža
0,29 €
EPS
−0,38 €
Dionice u optjecaju
37,66 mil.
Broj djelatnika
228
Otvori
0,44 €
Najviša
0,45 €
Najniža
0,44 €
Trž. kap.
31,86 mil.
Prosj. kol.
136,90 tis.
Količina
0,00
52-tjed. najviša
1,04 €
52-tjed. najniža
0,29 €
EPS
−0,38 €
Dionice u optjecaju
37,66 mil.
Broj djelatnika
228
Vijesti
Iz web-izvora i od partnera za vijesti
Adam Feldman | Substack
·
prije 12 sati
Inside the Federal Litigation of Five S&P 500 Giants
Benzinga
·
prije 46 minuta
Stock Market: Will S&P 500 Open Up or Down Today?
The Harvard Law School Forum on Corporate Governance
·
prije 18 sati
Board Practices and Composition in the Russell 3000 and S&P 500
The Motley Fool
·
prije 7 sati
The Semiconductor ETF Is on Track to Beat the S&P 500 for a 4th Straight Year. It Has Never Done That Before.
Profil
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Novacyt SA – informacije
Glavni izvršni direktorDavid Allmond
Zaposlenici228
Osnovano3. srp 2006.
Sjedište-
SektorHealth Care
Djelatnost-
Web-lokacijanovacyt.com